Literature DB >> 11779151

Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization.

Anja Altmann1, Lutz Fischer, Manfred Schubert-Zsilavecz, Dieter Steinhilber, Oliver Werz.   

Abstract

Here we show that extracts of Boswellia serrata gum resins and its constituents, the boswellic acids (BAs), activate the mitogen-activated protein kinases (MAPK) p42(MAPK) and p38 in isolated human polymorphonuclear leukocytes (PMNL). MAPK activation was rapid and transient with maximal activation after 1-2.5 min of exposure and occurred in a dose-dependent manner. The keto-BAs (11-keto-beta-BA and 3-O-acetyl-11-beta-keto-BA) gave substantial kinase activation at 30 microM, whereas other BAs lacking the 11-keto group were less effective. Moreover, 11-keto-BAs induced rapid and prominent mobilization of free Ca(2+) in PMNL. Inhibitor studies revealed that phosphatidylinositol 3-kinase (PI 3-K) is involved in BA-induced MAPK activation, whereas a minor role was apparent for protein kinase C. MAPK activation by 3-O-acetyl-11-beta-keto-BA was partially inhibited when Ca(2+) was removed by chelation. Our results suggest that 11-keto-BAs might function as potent activators of PMNL by stimulation of MAPK and mobilization of intracellular Ca(2+). (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779151     DOI: 10.1006/bbrc.2001.6153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.

Authors:  Daniel Poeckel; Lars Tausch; Anja Altmann; Christian Feisst; Ute Klinkhardt; Jochen Graff; Sebastian Harder; Oliver Werz
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 2.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

3.  Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes.

Authors:  Anja Altmann; Daniel Poeckel; Lutz Fischer; Manfred Schubert-Zsilavecz; Dieter Steinhilber; Oliver Werz
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

4.  Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model.

Authors:  Xiao Ni; Mahmoud M Suhail; Qing Yang; Amy Cao; Kar-Ming Fung; Russell G Postier; Cole Woolley; Gary Young; Jingzhe Zhang; Hsueh-Kung Lin
Journal:  BMC Complement Altern Med       Date:  2012-12-13       Impact factor: 3.659

5.  Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.

Authors:  Mahmoud M Suhail; Weijuan Wu; Amy Cao; Fadee G Mondalek; Kar-Ming Fung; Pin-Tsen Shih; Yu-Ting Fang; Cole Woolley; Gary Young; Hsueh-Kung Lin
Journal:  BMC Complement Altern Med       Date:  2011-12-15       Impact factor: 3.659

6.  Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis).

Authors:  P K Gupta; S M S Samarakoon; H M Chandola; B Ravishankar
Journal:  Ayu       Date:  2011-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.